Research and Markets: European Cystic Fibrosis Market 2015-2019 - Key Vendors are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis & Vertex Pharmaceuticals

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7szfkp/cystic_fibrosis) has announced the addition of the "Cystic Fibrosis Market in Europe 2015-2019" report to their offering.

The Cystic Fibrosis market in Europe to grow at a CAGR of 35.10% over the period 2014-2019.

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children.

Growing awareness among the medical fraternity, patients, and families of patients is one key trend being witnessed in this market. This increases the number of patients seeking treatment and results in growth in the overall consumption of medicines.

According to the report, high unmet medical needs are one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely and, hence, the resultant mortality rate is high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market.

Further, the report states that high cost of drugs is one of the major challenges restricting the growth of the market. Drugs used for the treatment of cystic fibrosis are expensive and, hence, get a poor response from patients. Patients also tend to withdraw from expensive treatment regimens.

To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of cystic fibrosis including:

  • Small Molecules
  • Biologics

Key Vendors

  • Actavis
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • Novartis
  • Vertex Pharmaceuticals

Other Prominent Vendors

  • Abbott
  • Anthera Pharmaceuticals
  • Arcturus Therapeutics
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • Corbus Pharmaceuticals
  • Genzyme
  • Insmed
  • Johnson & Johnson
  • Merck Sharp & Dohme
  • Neovii Biotech
  • Novo Nordisk
  • PharmaSwiss
  • Pharmaxis
  • Proteostasis Therapeutics
  • PTC Therapeutics
  • United Medical
  • Venus Remedies

For more information visit http://www.researchandmarkets.com/research/7szfkp/cystic_fibrosis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices